companyprofile

Actions

Saudi Pharmaceutical Industries and Medical Appliances Corp.

2070
SPIMACO
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Pharma, Biotech & Life Science

Stats Overview

  • Prev. Close 29.45
  • Open 29.30
  • High 29.40
  • Low 28.50
  • No. of Trades 2,569
  • Avg. Trade size* 342
  • Volume Traded 878,830
  • Value Traded (SAR) 25,404,810.80

Performance

SPIMACO
-0.75 ( -2.55% )
Compare
Name Price Change %
Saudi Pharmaceutical Industries and Medical Appliances Corp. 29.30 -2.55%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
28.70
% Change
-2.55
Volume Traded
1,000

Best Bid

Price 28.65
Volume 230

Best Offer

Price 28.70
Volume 11,173

52 WEEK

High
45.25
2023/06/18
Low
27.45
2023/10/24
Change**
-31.67

PERFORMANCE

Start of Year
38.05
Year ago
42
3 Years ago
56

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Saudi Pharmaceutical Industries and Medical Appliances Corp. Announces an update on the external auditor.

    2070
    SPIMACO -2.55 %
    1445/12/07     13/06/2024 15:39:39
  • Addendum Announcement from Saudi Pharmaceutical Industries and Medical Appliances Corp. in regards to re-attaching a document in Arabic language to one of the terms of the extraordinary general assembly meeting.

    2070
    SPIMACO -2.55 %
    1445/12/04     10/06/2024 15:54:11
  • The Saudi Pharmaceutical Industries and Medical Supplies Company, invites its shareholders to attend the extraordinary general assembly meeting in person and through modern technological means (the third meeting).

    2070
    SPIMACO -2.55 %
    1445/12/03     09/06/2024 19:44:12
  • Saudi Pharmaceutical Industries and Medical Appliances Corp. announces the non-convening of the Extraordinary General Assembly’s Meeting of the Company ( First Meeting )

    2070
    SPIMACO -2.55 %
    1445/11/26     03/06/2024 09:52:52
  • Saudi Pharmaceutical Industries and Medical Appliances Corp. announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )

    2070
    SPIMACO -2.55 %
    1445/11/08     16/05/2024 15:33:46
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      24/03/2022 08/06/2022 27/06/2022 Account Transfer 0.60
      23/03/2021 30/05/2021 16/06/2021 Account Transfer 1.00
      31/03/2020 14/05/2020 11/06/2020 Account Transfer 0.50
      05/03/2019 02/04/2019 18/04/2019 Account Transfer 1.00
      31/07/2018 30/08/2018 20/09/2018 Account Transfer 0.50

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2023-12-31
      Total Assets
      4,023,861
      - - -
      Total Liabilities
      2,355,830
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      1,506,649
      - - -
      Total Liabilities and Shareholders Equity
      3,862,479
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      1,653,084
      - - -
      Net Profit (Loss) before Zakat and Tax
      36,184
      - - -
      Zakat and Income Tax
      -45,260
      - - -
      Net Profit (Loss) after Zakat and Tax
      -9,076
      - - -
      Total Comprehensive Income
      -7,296
      - - -
      Profit (Loss) per Share
      -0.11
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      47,734
      - - -
      Net Cash From Investing Activities
      -171,570
      - - -
      Net Cash From Financing Activities
      -32,277
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      335,349
      - - -
      Cash and Cash Equivalents, End of the Period
      163,090
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-04-14

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2024-03-31 2023-09-30
      Total Assets
      4,355,660
      4,131,250
      Total Liabilities
      2,642,984
      2,426,192
      Total Shareholders Equity (After Deducting the Minority Equity)
      1,547,015
      1,549,446
      Total Liabilities and Shareholders Equity
      4,355,660
      4,131,250
      Statement of Income 2024-03-31 2023-09-30
      Total Revenue (Sales/Operating)
      475,403
      381,620
      Net Profit (Loss) before Zakat and Tax
      45,995
      -34,027
      Zakat and Income Tax
      -6,701
      -4,373
      Net Profit (Loss) after Zakat and Tax
      39,888
      -38,400
      Total Comprehensive Income
      44,645
      -44,929
      Profit (Loss) per Share
      0.3
      -0.34
      Cash Flow 2024-03-31 2023-09-30
      Net Cash From Operating Activities
      -48,133
      -85,183
      Net Cash From Investing Activities
      -28,989
      -110,552
      Net Cash From Financing Activities
      136,270
      -4,398
      Cash and Cash Equivalents, Beginning of the Period
      163,090
      335,349
      Cash and Cash Equivalents, End of the Period
      228,189
      135,216
      All Figures in Thousands Thousands
      All Currency In SAR SAR
      Last Update Date 2024-05-20 2023-11-27

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-06-13 احمد حمدان ناصر الجديع Chairman 0.0002567% 0.0002567% 0
      2024-06-13 مي عبدالله عبدالرحمن العجاجي Board of Directors 0.0000417% 0.0000417% 0
      2024-06-13 عبدالرحمن محمد عبدالرحمن الثنيان Board of Directors 0.0014042% 0.0014042% 0
      2024-06-13 فهد عبدالعزيز محمد الربيعه Board of Directors 0.0225000% 0.0225000% 0
      2024-06-13 خالد عبدالرحمن عبدالله القويز Board of Directors 0.0086642% 0.0086642% 0
      2024-06-13 فيصل محمد امين شاكر Board of Directors 0.0008333% 0.0008333% 0
      2024-06-13 عمار عبدالواحد فالح الخضيري Board of Directors 0.0008333% 0.0008333% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Saudi Pharmaceutical Industries and Medical Appliances Corp.
      Price 28.70
      Market Cap (SAR MN) 3,534
      P/E Ratio -
      Index Name Index Level 1D Return
      Saudi Pharmaceutical Industries and Medical Appliances Corp. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      It was established in January 1986 with the main objective of setting up an advanced pharmaceutical industry in the Kingdom of Saudi Arabia, for the local production of pharmaceutical products and medical appliances and to market these products inside the Kingdom and abroad.

      Company History

      SPIMACO is a Saudi Joint-Stock Company with a fully paid up capital of SR 1,200,000,000

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 1,200,000,000
      • Issued Shares 120,000,000
      • Paid Capital (SAR) 1,200,000,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2014-04-17

      Investment limits

      There are no investment limits on the company s shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company s bylaw and the issued instructions by the related regulators and supervisory authorities

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        1986/01/20

      • Financial Year End

        31/12

      • Listing Date

        1994/01/01

      • External Auditors

        [Baker Tilly MKM & Co]

      • ISIN CODE

        SA0007879188

      • Number of Employees

        -

      • Chairman

        Dr.Ahmed bin Hamdan Aljedai
        Independent

        Dr.Ahmed bin Hamdan Aljedai
        • BD Session Start
          2023-11-09
          Designation
          Chairman
        • BD Session End
          2025-04-02
          Classification
          Independent
      • Board of Directors

        Mr. Ammar Abdulwahed Alkhudairy Deputy Chairman - Independent

        Mr. Ammar Abdulwahed Alkhudairy
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Deputy Chairman - Independent

        Eng. Adil Kareem kak Ahmed Non - Executive

        Eng. Adil Kareem kak Ahmed
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Non - Executive

        Dr.Mohammad Khalil Mohammad Mohammad Non - Executive

        Dr.Mohammad Khalil Mohammad Mohammad
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Non - Executive

        Mr. Faisal Mohammed Shaker Non - Executive

        Mr. Faisal Mohammed Shaker
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Non - Executive

        Mr. Khalid A. Algwaiz Non - Executive

        Mr. Khalid A. Algwaiz
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Non - Executive

        Mr.Abdulrhman Mohammed Al Thinyan Independent

        Mr.Abdulrhman Mohammed Al Thinyan
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Independent

        Dr.Mai Abullah Alajaji Independent

        Dr.Mai Abullah Alajaji
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Independent

        Dr.Fahad Abdulaziz Alrabiah Independent

        Dr.Fahad Abdulaziz Alrabiah
        • BD Session Start
          2022-04-03
          Designation
          Board of Directors
        • BD Session End
          2025-04-02
          Classification
          Independent
      • Senior Executives

        Mr.Jerome Cabannes CEO

        Mr.Jerome Cabannes
        • BD Session Start
          2023-10-01
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO

        Mr.Atef Zouari CFO

      Mr.Atef Zouari
      • BD Session Start
        2024-01-04
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Investor Relations Department

      Company Address:

      Al-Qassim 2597 Buraydah- Riyad - Prince Salman Bin Muhammed Bin Saud street - AS SAHAFAH P.O.Box 20001 Riyadh 11455

      Contact Details:

      Telephone: +966 (11) 2523320
      Fax : +966 (11) 2523300
      Email : investor.relations@spimaco.sa

      Company Website:

      www.spimaco.com.sa


      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.